An Open Label, Randomized Comparison of Femara 2.5mg Once Daily With or Without Weekly Herceptin Until Disease Progression as First-line Treatment in Postmenopausal Women With Advanced Breast Cancer.
Phase of Trial: Phase IV
Latest Information Update: 12 Dec 2009
At a glance
- Drugs Letrozole; Trastuzumab
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Acronyms eLEcTRA
- 12 Dec 2009 Actual number of patients changed from 93 to 92 according to an abstract from the 32nd Annual San Antonio Breast Cancer Symposium.
- 12 Dec 2009 Results presented at the 32nd Annual San Antonio Breast Cancer Symposium.
- 11 Aug 2009 Actual patient number (93) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History